Allergic Rhinitis Market Share

North America Market Statistics

By 2037, North America allergic rhinitis market is anticipated to hold more than 45.5% share. The growth is stimulated owing to the increased indoor living and exposure to dust mites, pet dander, and other allergens. In addition, the in-built air conditioning systems with heating systems stimulate the circulation of allergens resulting in increased prevalence.

Canada allergic rhinitis market is anticipated to register considerable growth during the forecast period. The major characteristic of the Canada landscape for the allergic rhinitis market is the emerging demand for effective treatments as air pollution surges and climate change advances, coupled with a heightened awareness of environmental allergens more than ever. For instance, in August 2024, it was published that up to 20% of the general population in Canada is estimated to have a diagnosis of allergic rhinitis due to rising air pollution and changing environmental conditions.

The U.S. landscape is transforming through a shift towards even more personalized and convenient treatment options, such as SLIT and improved nasal sprays, further fueling the growth in the sector. In addition, the regulatory structure boosts the development of treatment options for allergic rhinitis. For instance, in March 2023, the U.S. FDA approved the ZAVZPRET, a nasal spray developed by Pfizer. This spray is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults.

Asia Pacific Market Analysis

Asia Pacific is the most rapidly growing region in the allergic rhinitis market, driven by the increasing pollutants in the air such as particulate matter and vehicular emissions. It fuels the cases of allergic rhinitis amongst the population thus increasing the need for timely diagnosis. In addition, the majority of the population in this region is inclusive middle-class which seeks affordable treatment options for allergic rhinitis.

The primary growth driver for the allergic rhinitis market in India is fueled by the all-around increasing urbanization, gradual aggravation of air pollution, and lifestyle changes that trigger a higher incidence of allergic conditions. For instance, in October 2024, it was published in the Economic Times that Bengaluru, with rapid urbanization and huge high-rise construction, has faced an all-year-long pollination allergy that has posed a health threat to its citizens. Environmental reduction in air quality and sudden climate changes have been separately aggravating this issue present at this point.

The allergic rhinitis market in China is evolving at a steady pace attributable to rising activities toward research into the root cause of allergic rhinitis and its treatments. For instance, in October 2024, it was published that researchers in China found that a change in the morphology of an immune receptor plays a significant role in allergic reactions. Such a discovery may bring new, useful insight into the development of allergy medicines. Moreover, the market is witnessing both expansion in treatment options and increasing demand for customized therapies with greater efficacy and fewer side effects.